Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The management of gout

Article Abstract:

The treatment of gout includes medication and an attempt at reversing contributing factors. Gout results from the deposit of urate crystals in joints or cartilage, causing inflammation and episodes of arthritis. Drugs for gout consist of colchicine, nonsteroidal antiinflammatory drugs, and corticosteroids. Colchicine causes diarrhea and abdominal pain, unless intravenously administered. Side effects limit the use of otherwise effective antiinflammatory drugs. Corticosteroid injections into the affected joint have been a very successful alternative to the other two types of medications. The production of urate can be prevented by a low-purine diet, weight control, and low alcohol consumption. Limiting the intake of foods high in purines may correct excessive amounts of uric acid in the blood. Organ meats, yeast, legumes, oatmeal, and asparagus contain high levels of purine.

Author: Emmerson, Bryan T.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
Drug therapy, Obesity, Corticosteroids, Adrenocortical hormones, Hyperuricemia, Colchicine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The severe gout of Holy Roman Emperor Charles V

Article Abstract:

The findings of massive gouty tophi with demonstrable urate deposits that confirm the clinical suspicion of severe gout in the unique sample from the mummified remains of the Holy Roman Emperor Charles V are reported. The evidence has confirmed that Charles V had severe gout, which was probably a determining factor in his decision to abdicate, and has illustrated how paleopathological studies can provide important information leading to an increased understanding of history.

Author: Campo, Elias, Ordi, Jaume, de Zulueta, Julian, Esteban, Jordi, Alonso, Pedro L., Velasco, Martin, Mas, Ernest, Fernandez, Pedro L.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Charles V, Holy Roman Emperor

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gout

Article Abstract:

The prevention and treatment of gout are reviewed based on the case of a 59-year-old man. Gout is a form of arthritis that is caused by deposits of uric acid crystals in joints. Humans cannot metabolize uric acid, so excess amounts in the blood will form crystals. Men are seven to nine times more likely to develop gout than women.

Author: Terkeltaub, Robert A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Prevention

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Gout, Care and treatment
Similar abstracts:
  • Abstracts: The advantages of using triple-marker screening for chromosomal abnormalities. Maternal serum alpha-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus
  • Abstracts: Effects of erythromycin on contractility of isolated myometrium from pregnant rats. Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio
  • Abstracts: The new frontier of reproductive age. A couple with infertility. Diagnosis and management of female infertility
  • Abstracts: Merck's recall of rofecoxib - A strategic perspective. Cost-effectiveness of cervical-cancer screening in five developing countries
  • Abstracts: Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.